Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01649
|
|||||
| Drug Name |
Metkephamid
|
|||||
| Synonyms |
METKEFAMIDE; UNII-MNL20FXH9Y; MNL20FXH9Y; Metkephamid; Metkephamide; Metkefamida; Metkefamidum; L-Methioninamide, L-tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-; Metkefamidum [INN-Latin]; Metkefamida [INN-Spanish]; L-Tyrosyl-D-alanylglycyl-L-phenylalanyl-N2-methyl-L-methioninamide; Metkefamide [INN]; AC1NUZ1B; SCHEMBL329997; CHEMBL2220405; CTK2F4766
|
|||||
| Indication | Pain [ICD11: MG30-MG7Z] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H40N6O6S
|
|||||
| Canonical SMILES |
CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)N(C)C(CCSC)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N
|
|||||
| InChI |
InChI=1S/C29H40N6O6S/c1-18(33-28(40)22(30)15-20-9-11-21(36)12-10-20)27(39)32-17-25(37)34-23(16-19-7-5-4-6-8-19)29(41)35(2)24(26(31)38)13-14-42-3/h4-12,18,22-24,36H,13-17,30H2,1-3H3,(H2,31,38)(H,32,39)(H,33,40)(H,34,37)/t18-,22+,23+,24+/m1/s1
|
|||||
| InChIKey |
FWDIKROEWJOQIQ-JMBSJVKXSA-N
|
|||||
| CAS Number |
CAS 66960-34-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 600.7 | Topological Polar Surface Area | 222 | ||
| Heavy Atom Count | 42 | Rotatable Bond Count | 16 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
0.9
|
|||||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Analgesic efficacy of parenteral metkephamid acetate in treatment of postoperative pain. Lancet. 1982 Jun 19;1(8286):1374-5. | |||||
| 2 | Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012 Sep 15;20(18):5388-95. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.